EU Project Set up to Fight Alzheimer’s Disease with Lasers
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s…
07/02/2020 - 3 minutes
Neurological disorders
Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder
Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI…
04/02/2020 - 2 minutes
As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?
With big pharma exiting the neurology space in droves, biotech innovation might be the key…
09/12/2019 - 9 minutes
Orchard’s Gene Therapy Improves Children’s Motor Ability
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than…
05/09/2019 - 3 minutes
This Biotech Treats a Neurological Autoimmune Disorder Using DNA
We’re jumping into Poland this week. Pure Biologics is a biotech based in Wrocław developing…
31/05/2019 - 4 minutes
Swiss Biotech Raises €20M to Develop Decoy Drugs in Autoimmune Disease
The biotech Polyneuron has raised a Series A round of €20.1M (CHF 22.5M) to start…
28/03/2019 - 2 minutes
Brain Metabolomics: A New Angle on Neurodegenerative Disorders
Neurodegenerative disorders, such as Alzheimer’s disease and multiple sclerosis (MS), are notoriously difficult to treat…
14/05/2018 - 5 minutes
Early Autism Diagnosis Could be Possible With New Blood and Urine Tests
The detection of damaged proteins in blood and urine tests could help to diagnose autism…
21/02/2018 - 3 minutes
Meet the Spin-Out Queen Taking on Neurological Diseases
Mary Kerr, CEO of NeRRe and Managing Director of KanDy, told us how its approaches…
09/11/2017 - 4 minutes
French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s
Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline…
30/10/2017 - 4 minutes
New Dutch Spin Out will Treat Stroke with RNA Therapy
ProQR has spun out Amylon Therapeutics, a company that will treat central nervous system disorders…
14/09/2017 - 2 minutes
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…
06/06/2017 - 7 minutes
